Tech Company Financing Transactions
Nucleix Funding Round
Aurum Ventures MKI, private investors and OrbiMed joined a $3 million venture round for Nucleix. This VC investment round was announced on 5/25/2016.
Transaction Overview
Company Name
Announced On
5/25/2016
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12707 High Bluff Dr. 200
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Undisclosed
Website
Email Address
Overview
Nucleix, Ltd. operates as a life sciences company. The company provides forensic Deoxyribonucleic acid (DNA) analysis. It develops the Bladder EpiCheck, urinalysis product for non-invasive diagnosis of bladder cancer and monitoring its treatment. The company was founded in 2008 and is based in Tel Aviv, Israel.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Hibberd
Chief Medical Officer
Aharona Shuali
Vice President
Danny Frumkin
Vice President
Adam Wasserstrom
VP - Product Management
Eran Bram
VP - Regulatory Affairs
Shmulik Adler
VP - Sales
Ricardo ten Velden
Browse more venture capital transactions:
Prev: 5/25/2016: SilverVue venture capital transaction
Next: 5/25/2016: Molekule venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs